Ligand Pharmaceuticals Incorporated (LGND)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$6.28B
EV to revenue ratio (TTM)
27.43
EV to ebitda
72.63
Financial Performance
Revenue (TTM)
$0.25B
Gross profit (TTM)
$0.22B
EBITDA
$0.07B
Profitability
Operating margin (TTM)
-12.00%
Profit margin
20.30%
Return on assets (TTM)
1.23%
Return on equity (TTM)
5.38%
Per Share Metrics
Revenue per share (TTM)
$12.83
EPS
$2.49
Diluted EPS (TTM)
$2.49
Book value
$48.09
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
126.17
Trailing P/E
126.17
Forward P/E
25.45
PEG ratio
1.53
Price to sales ratio (TTM)
24.76
Price to book ratio (TTM)
6.53
Growth
Quarterly earnings growth (YoY)
-31.80%
Quarterly revenue growth (YoY)
825.00%
Analyst Sentiment
Strong buy
3
Buy
8
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.04